Read More 1 minute read Analyst Ratings Downgrades News Price Target Exane BNP Paribas Downgrades Freeport-McMoRan to Neutral, Announces $29 Price Target By Benzinga Newsdesk October 6, 6:16 AM Exane BNP Paribas analyst Jatinder Goel downgrades Freeport-McMoRan (NYSE:FCX) from Outperform to Neutral and announces $29 price target. FCX
Read More 1 minute read Analyst Ratings Downgrades News Price Target Goldman Sachs Downgrades Reliance Steel & Aluminum to Neutral, Lowers Price Target to $201 By Benzinga Newsdesk October 6, 4:55 AM Goldman Sachs analyst Emily Chieng downgrades Reliance Steel & Aluminum (NYSE:RS) from Buy to Neutral and lowers the price target from $218 to $201. RS
Read More 1 minute read Analyst Ratings Downgrades News Keybanc Downgrades BTRS Holdings to Sector Weight By Benzinga Newsdesk October 6, 4:31 AM Keybanc analyst Josh Beck downgrades BTRS Holdings (NASDAQ:BTRS) from Overweight to Sector Weight. BTRS
Read More 1 minute read Analyst Ratings Downgrades News Citigroup Downgrades Diversey Hldgs to Neutral By Benzinga Newsdesk October 5, 8:03 AM Citigroup analyst PJ Juvekar downgrades Diversey Hldgs (NASDAQ:DSEY) from Buy to Neutral. DSEY
Read More 1 minute read Analyst Ratings Downgrades News Price Target Credit Suisse Downgrades Janus Henderson Gr to Underperform, Announces $19 Price Target By Benzinga Newsdesk October 5, 6:27 AM Credit Suisse analyst James Cordukes downgrades Janus Henderson Gr (NYSE:JHG) from Neutral to Underperform and announces $19 price target. JHG
Read More 1 minute read Analyst Ratings Downgrades News Price Target Barclays Downgrades Poshmark to Equal-Weight, Raises Price Target to $18 By Benzinga Newsdesk October 5, 6:26 AM Barclays analyst Trevor Young downgrades Poshmark (NASDAQ:POSH) from Overweight to Equal-Weight and raises the price target from $17 to $18. POSH
Read More 1 minute read Analyst Ratings Downgrades News Price Target Citigroup Downgrades Sotera Health to Neutral, Announces $9 Price Target By Benzinga Newsdesk October 5, 6:22 AM Citigroup analyst Patrick Donnelly downgrades Sotera Health (NASDAQ:SHC) from Buy to Neutral and announces $9 price target. SHC
Read More 1 minute read Analyst Ratings Downgrades News Price Target B of A Securities Downgrades Sportradar Gr to Underperform, Lowers Price Target to $8 By Benzinga Newsdesk October 4, 10:02 AM B of A Securities analyst Shaun Kelley downgrades Sportradar Gr (NASDAQ:SRAD) from Neutral to Underperform and lowers the price target from $14 to $8. SRAD
Read More 1 minute read Analyst Ratings Downgrades News Price Target B of A Securities Downgrades Membership Collective to Underperform, Lowers Price Target to $4 By Benzinga Newsdesk October 4, 9:24 AM B of A Securities analyst Shaun Kelley downgrades Membership Collective (NYSE:MCG) from Buy to Underperform and lowers the price target from $12 to $4. MCG
Read More 1 minute read Analyst Ratings Downgrades News Price Target Wedbush Downgrades Poshmark to Neutral, Announces $17.5 Price Target By Benzinga Newsdesk October 4, 8:35 AM Wedbush analyst Tom Nikic downgrades Poshmark (NASDAQ:POSH) from Outperform to Neutral and announces $17.5 price target. POSH